EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease

Jes Paul

Journal of Neuroscience and Neurological Disorders · 2018

DOI: 10.29328/journal.jnnd.1001014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroscience and Neurological Disorders, 2018. Verfasst von Jes Paul. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ailment repairing regiments has turn out to be arduous, despite a plenty of understanding and knowledge acquired in the past relating to the molecular underpinnings of Alzheimer’s disease (AD. Umpteen clinical experiments targeting the fabrication and accumulation have been turned fruitless to fit potency standards. The tests aiming beta-amyloid hypothesis also turned futile making it exigent for further handling tactics. The new emanation of a comparably candid, economical, and punctilious system known as gene editing have showed light in path of cure for AD by CRISPR/Cas9 gene editing. Being a straight approach this procedure has already shown assurance in other neurological disorders too such as Huntington’s disease. This review standpoint the immanent service of CRISPR/Cas9 as a remedial option for AD by aiming on specific genes inclusive of those that induce early-onset AD, as well as those that are substantial risk components for late-onset AD such as the apolipoprotein E4 (APOE4) gene.

Zitieren

APA

Paul, J. (2018). Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease. Journal of Neuroscience and Neurological Disorders. https://doi.org/10.29328/journal.jnnd.1001014

Vancouver

Paul J. Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease. Journal of Neuroscience and Neurological Disorders. 2018. doi:10.29328/journal.jnnd.1001014

BibTeX
@article{Paul2018,
  author = {Paul, Jes},
  title = {Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease},
  journal = {Journal of Neuroscience and Neurological Disorders},
  year = {2018},
  doi = {10.29328/journal.jnnd.1001014}
}
Kostenlos starten →